Source: Blood. Conference titles: ASH Annual Meeting Abstracts. Unidade: FMRP
Subjects: CICLOSPORINAS, ANEMIA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VALLEJO, Carlos et al. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. Disponível em: https://doi.org/10.1182/blood-2021-147733. Acesso em: 23 out. 2025. , 2021APA
Vallejo, C., Jang, J. H., Finelli, C., Montaño Figueroa, E., Norasetthada, L., Calado, R. T., et al. (2021). Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study. Blood. Washington: Faculdade de Medicina de Ribeirão Preto, Universidade de São Paulo. doi:10.1182/blood-2021-147733NLM
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2025 out. 23 ] Available from: https://doi.org/10.1182/blood-2021-147733Vancouver
Vallejo C, Jang JH, Finelli C, Montaño Figueroa E, Norasetthada L, Calado RT, Turgut M, Peffault de Latour R, Kriemler-Krahn U, Haenig J, Maier J, Scheinberg P. Efficacy and safety of eltrombopag combined with cyclosporine as first-line therapy in adults with severe acquired aplastic anemia: results of the interventional phase 2 single-arm soar study [Internet]. Blood. 2021 ; 138 2174-2175.[citado 2025 out. 23 ] Available from: https://doi.org/10.1182/blood-2021-147733
